Novel Technique of Pneumatic Posterior Capsulorhexis for Treatment and Prevention of Posterior Capsular Opacification
Table 1
Postoperative visual and refractive outcomes in both of the groups.
Parameters
Group 1
Group 2
value
UCVA
Mean
Mean
3 months
0.75 ± 0.08
0.80 ± 0.050
0.82
6 months
1.01 ± 0.112
1.03 ± 0.96
1.0
12 months
1.034 ± 0.85
1.024 ± 0.65
0.95
BCVA
Mean
Mean
3 months
0.96 ± 0.056
0.993 ± 0.035
0.90
6 months
1.036 ± 0.095
1.037 ± 0.15
1.0
12 months
1.040 ± 0.085
1.044 ± 0.075
1.0
MRSE
Mean
Mean
1 month
−1.75 ± 2.50 D
−1.65 ± 2.00 D
0.88
3 months
−1.25 ± 1.50 D
−1.35 ± 1.25 D
0.95
6 months
−0.65 ± 1.25 D
−0.50 ± 1.38 D
0.98
12 months
−0.75 ± 1.05
−0.75 ± 1.03 D
1.0
UCVA = uncorrected visual acuity, BCVA = best corrected visual acuity, and MRSE = manifest refractive spherical equivalent. There were no statistically significant differences in the means of both of the groups. was considered statistically significant.
